×
About 9,830 results

ALLMedicine™ Heart Transplantation Center

Research & Reviews  3,708 results

Analysis of the 2020 EACTS/ELSO/STS/AATS Expert Guidelines on the Management of Adult P...
https://doi.org/10.1053/j.jvca.2021.06.022
Journal of Cardiothoracic and Vascular Anesthesia; Welker C, Huang J et. al.

Aug 2nd, 2021 - Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), increasingly is used in postcardiotomy (PC) shock to facilitate a bridge to sustained recovery, long-term mechanical support, or heart transplantation. G...

An unusual tachycardia - Tale of a hidden P wave.
https://doi.org/10.1016/j.jelectrocard.2021.07.018
Journal of Electrocardiology; Pothineni NVK, Smietana J et. al.

Aug 2nd, 2021 - Traditional rules of arrhythmia mechanisms may not apply in altered anatomical states such as heart transplantation. We present a case of a young man presenting with incessant tachycardia that violates routine electrocardiographic criteria for rhy...

The Stanford experience of heart transplantation over five decades.
https://doi.org/10.1093/eurheartj/ehab416
European Heart Journal; Zhu Y, Lingala B et. al.

Aug 2nd, 2021 - Since 1968, heart transplantation has become the definitive treatment for patients with end-stage heart failure. We aimed to summarize our experience in heart transplantation at Stanford University since the first transplantation performed over 50...

Trends, Prevalence, and Outcomes of Sudden Cardiac Arrest Post Cardiac Transplant: A Na...
https://doi.org/10.1016/j.cpcardiol.2021.100901
Current Problems in Cardiology; Isath A, Rao SD et. al.

Aug 1st, 2021 - Heart transplantation is the most effective long-term therapy for end-stage heart disease. There is limited data related to sudden cardiac arrest (SCA) in postheart transplant recipients. We aimed to describe the trends, and rate of SCA following ...

Long-Term Outcome After Venoarterial Extracorporeal Membrane Oxygenation as Bridge to L...
https://doi.org/10.1053/j.jvca.2021.06.035
Journal of Cardiothoracic and Vascular Anesthesia; Coeckelenbergh S, Valente F et. al.

Aug 1st, 2021 - To determine if venoarterial extracorporeal membrane oxygenation (VA ECMO) as a bridge to left ventricular assist device (LVAD) in heart transplant (HT) candidates (ie, double bridge to HT) was associated with increased morbidity and mortality whe...

see more →

Guidelines  3 results

Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement ...
https://doi.org/10.1016/j.cjca.2019.12.025
The Canadian Journal of Cardiology; Chih S, McDonald M et. al.

Mar 9th, 2020 - Significant practice-changing developments have occurred in the care of heart transplantation candidates and recipients over the past decade. This Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement provides evid...

Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardiove...
https://doi.org/10.1016/j.cjca.2016.09.009
The Canadian Journal of Cardiology; Bennett M, Parkash R et. al.

Dec 31st, 2016 - Sudden cardiac death is a major public health issue in Canada. However, despite the overwhelming evidence to support the use of implantable cardioverter defibrillators (ICDs) in the prevention of cardiac death there remains significant variability...

The 2016 International Society for Heart Lung Transplantation listing criteria for hear...
https://doi.org/10.1016/j.healun.2015.10.023
The Journal of Heart and Lung Transplantation : the Offic... Mehra MR, Canter CE et. al.

Jan 19th, 2016 - The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.|2016|Mehra MR,Canter CE,Hannan MM,Semigran MJ,Uber PA,|standards,supply & distribution,

see more →

Drugs  5 results see all →

Clinicaltrials.gov  83 results

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
https://clinicaltrials.gov/ct2/show/NCT03383419

Apr 24th, 2020 - utilizing HCV-positive donors (defined as HCV-NAT positive) for heart transplantation in HCV-negative recipients treated with Epclusa®. Subjects will be identified from the heart transplantation waitlist. Subjects who, according to the judgement o...

Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey
https://clinicaltrials.gov/ct2/show/NCT02479503

Apr 14th, 2020 - In adult heart transplantation, clinical situations differ between patients (elective, emergency, redux surgery, ventricular assisting device or extracorporeal live saving). At investigator's knowledge, there is not recommendations in France about...

Levosimendan In Patients Undergoing LVAD Implantation
https://clinicaltrials.gov/ct2/show/NCT03659851

Apr 3rd, 2020 - Left ventricular assist device (LVAD) implantation is accepted for treatment of end-stage heart failure, in both as the bridging to heart transplantation or as the destination therapy. These patients have highly impaired systolic function which co...

SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support?
https://clinicaltrials.gov/ct2/show/NCT02568930

Mar 6th, 2020 - The purpose of this study is to compare health-related quality of life (HRQOL) outcomes in older (60-80 years) advanced heart failure (HF) patients who undergo heart transplantation (HT) or mechanical circulatory support (MCS) as a permanent impla...

Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients
https://clinicaltrials.gov/ct2/show/NCT03662789

Mar 2nd, 2020 - Iron deficiency is prevalent in patients with heart failure. Iron deficiency is associated with a worse prognosis, and randomised controlled trials have shown that correction of iron deficiency with intravenous iron therapy improves functional cap...

see more →

News  131 results

Elderly Heart Transplant Patients Have 5-Year Survival Similar to Younger Recipients
https://www.medscape.com/viewarticle/953644

Jun 24th, 2021 - (Reuters Health) - Survival of elderly heart transplant recipients at five years is similar to that of younger recipients even though older adults are more likely to get organs from higher-risk donors, a recent study suggests. Researchers examined...

'Liquid Biopsy' Detects Acute Heart Transplant Rejection
https://www.medscape.com/viewarticle/944494

Jan 21st, 2021 - Levels of circulating, donor-derived cell-free DNA (ddcfDNA) can detect acute heart transplant rejection earlier than tissue biopsy and could eliminate about 80% of invasive heart tissue biopsies currently used to detect rejection, results of a va...

FDA OKs Abbott's HeartMate 3 LVAD for Use in Children
https://www.medscape.com/viewarticle/942924

Dec 18th, 2020 - The HeartMate 3 (Abbott) left ventricular assist device (LVAD) can now be used in pediatric patients with advanced refractory left ventricular heart failure who are awaiting heart transplantation or who are not candidates for heart transplantation...

Wide Variation in Post-Heart Transplant Pregnancy Practice Patterns
https://www.medscape.com/viewarticle/929300

Apr 24th, 2020 - (Reuters Health) - Practice patterns surrounding pregnancy after heart transplantation vary widely in the U.S. and many clinicians mistakenly believe that pregnancy is contraindicated in all cases, a recent survey suggests. "I believe practice pat...

Wide Variation in Post-Heart Transplant Pregnancy Practice Patterns
https://www.staging.medscape.com/viewarticle/929300

Apr 24th, 2020 - (Reuters Health) - Practice patterns surrounding pregnancy after heart transplantation vary widely in the U.S. and many clinicians mistakenly believe that pregnancy is contraindicated in all cases, a recent survey suggests. "I believe practice pat...

see more →

Patient Education  2 results see all →